NCT06596408 Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .
| NCT ID | NCT06596408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | High Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-09-11 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-09-11 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study aiming to evaluate Macular Vascular Density in High Myopes without pathological myopic maculopathy in outpatient clinic in Sohag teaching hospital using OCTA .
Eligibility Criteria
Inclusion Criteria wil include : * All myopic patients with axial high myopia (-6 spherical refractive error or more) of different age groups . Exclusion Criteria will include : * -History of other any ocular diseases , systemic diseases that may affect the ocular circulation . * Previous intraocular surgery or ocular injury . * Any patient with pathological myopic maculopathy as epiretinal membrane, foveoschisis, macular holes, lamellar holes, Lacquers cracks, choroidal neovascularization and retinal atrophy .
Contact & Investigator
Adham Salah Mohammed, lecturer
STUDY CHAIR
Sohag University
Frequently Asked Questions
Who can join the NCT06596408 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying High Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06596408 currently recruiting?
Yes, NCT06596408 is actively recruiting participants. Contact the research team at saramagdy@med.sohag.edu.eg for enrollment information.
Where is the NCT06596408 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06596408 clinical trial?
NCT06596408 is sponsored by Sohag University. The principal investigator is Adham Salah Mohammed, lecturer at Sohag University. The trial plans to enroll 50 participants.